IP Verse

Mnd Promoter Chimeric Antigen Receptors - EP3689899

The patent EP3689899 was granted to Bluebird BIO on Nov 24, 2021. The application was originally filed on Apr 24, 2015 under application number EP19218258A. The patent is currently recorded with a legal status of "Revoked".

EP3689899

BLUEBIRD BIO
Application Number
EP19218258A
Filing Date
Apr 24, 2015
Status
Revoked
Jun 21, 2025
Grant Date
Nov 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTJul 13, 2022BOULT WADE TENNANTADMISSIBLE

Patent Citations (45) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19470612416-
DESCRIPTIONWO1994US05601-
DESCRIPTIONEP0404097
DESCRIPTIONUS2003147869
DESCRIPTIONUS2006121005
DESCRIPTIONUS4554101
DESCRIPTIONUS4873192
DESCRIPTIONUS5283173
DESCRIPTIONUS5468614
DESCRIPTIONUS5585089
DESCRIPTIONUS5827642
DESCRIPTIONUS5858358
DESCRIPTIONUS5883223
DESCRIPTIONUS5994136
DESCRIPTIONUS6005079
DESCRIPTIONUS6013516
DESCRIPTIONUS6040177
DESCRIPTIONUS6352694
DESCRIPTIONUS6534055
DESCRIPTIONUS6682907
DESCRIPTIONUS6692964
DESCRIPTIONUS6797514
DESCRIPTIONUS6867041
DESCRIPTIONUS6887466
DESCRIPTIONUS6905680
DESCRIPTIONUS6905681
DESCRIPTIONUS6905874
DESCRIPTIONUS7067318
DESCRIPTIONUS7144575
DESCRIPTIONUS7172869
DESCRIPTIONUS7175843
DESCRIPTIONUS7232566
DESCRIPTIONWO02088346
DESCRIPTIONWO03057171
DESCRIPTIONWO2012129514
DESCRIPTIONWO2012170911
DESCRIPTIONWO9108442
DESCRIPTIONWO9301161
DESCRIPTIONWO9404678
DESCRIPTIONWO9425591
OPPOSITIONWO2012079000
OPPOSITIONWO2013154760
OPPOSITIONWO2016094304
SEARCHAU2013204923
SEARCHWO2014031687

Non-Patent Literature (NPL) Citations (90) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALT, M., J. Hepatol., (19950000), vol. 23, pages 746 - 58-
DESCRIPTION- ALTSCHUL et al., Nucl. Acids Res., (19970000), vol. 25, page 3389-
DESCRIPTION- ASHWOOD-SMITH, Nature, (19610000), vol. 190, pages 1204 - 1205-
DESCRIPTION- BELL et al., Cell, (19990000), vol. 98, page 387-
DESCRIPTION- BERG et al., Transplant Proc., (19980000), vol. 30, no. 8, pages 3975 - 3977-
DESCRIPTION- BIRD et al., Science, (19880000), vol. 242, pages 423 - 426-
DESCRIPTION- BORDEN, P.KABAT E. A., PNAS, (19870000), vol. 84, pages 2440 - 2443-
DESCRIPTION- BRODY, S. L.CRYSTAL, R. G., Ann. N.Y. Acad. Sci., (19940000), vol. 716, pages 90 - 101-
DESCRIPTION- BURGESS-BEUSSE et al., Proc. Natl. Acad. Sci., USA, (20020000), vol. 99, page 16433-
DESCRIPTION- CHALLITA et al., J Virol., (19950000), vol. 69, no. 2, pages 748 - 55-
DESCRIPTION- CHAUDHARY et al., Proc. Natl. Acad. Sci. U.S.A., (19900000), vol. 87, pages 1066 - 1070-
DESCRIPTION- CHOITHIA, C. et al., Nature, (19890000), vol. 342, pages 877 - 883-
DESCRIPTION- CHOITHIA, C.LESK, A.M., J Mol. Biol., (19870000), vol. 196, no. 4, pages 901 - 917-
DESCRIPTION- CHUNG et al., Cell, (19930000), vol. 74, page 505-
DESCRIPTION- CHUNG et al., PNAS, (19970000), vol. 94, page 575-
DESCRIPTION- CLEVER et al., J. of Virology, (19950000), vol. 69, no. 4, pages 2101 - 2109-
DESCRIPTION- CULLEN et al., Cell, (19910000), vol. 58, page 423-
DESCRIPTION- CULLEN et al., J. Virol., (19910000), vol. 65, page 1053-
DESCRIPTION- DEFELIPERYAN, Traffic, (20040000), vol. 5, no. 8, pages 616 - 26-
DESCRIPTION- DESJARLAISBERG, PNAS, (19930000), vol. 90, pages 2256 - 2260-
DESCRIPTION- DONNELLY et al., J. Gen. Virol., (20010000), vol. 82, pages 1027 - 1041-
DESCRIPTION- FERRY, N.HEARD, J. M., Hum. Gene Ther., (19980000), vol. 9, pages 1975 - 81-
DESCRIPTION- FIRE et al., Nature, (19980000), vol. 391, page 806-
DESCRIPTION- GARLAND et al., J. Immunol Meth., (19990000), vol. 227, no. 1 -2, pages 53 - 63-
DESCRIPTION- HAANEN et al., J. Exp. Med., (19990000), vol. 190, no. 9, page 13191328-
DESCRIPTION- HAMILTON et al., Science, (19990000), vol. 286, pages 886 - 951-
DESCRIPTION- HOLLINGER et al., PNAS USA, (19930000), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOLT, L. et al., Trends in Biotechnology, vol. 21, no. 11, pages 484 - 490-
DESCRIPTION- HUANG et al., Mol. Cell. Biol., vol. 5, page 3 864-
DESCRIPTION- HUDSON et al., Nat. Med., (20030000), vol. 9, pages 129 - 134-
DESCRIPTION- IRIONS et al., Nature Biotechnology, (20070000), vol. 25, pages 1477 - 1482-
DESCRIPTION- JACKSON et al., Trends Biochem Sci, (19900000), vol. 15, no. 12, pages 477 - 83-
DESCRIPTION- JACKSONKAMINSKI, RNA, (19950000), vol. 1, no. 10, pages 985 - 1000-
DESCRIPTION- KAY, M. A., Chest, (19970000), vol. 111, no. 6, pages 138S - 142S-
DESCRIPTION- KIM et al., PNAS, (19960000), vol. 93, pages 1156 - 1160-
DESCRIPTION- KOCH-NOLTE et al., FASEB J., (20070000), vol. 21, pages 3490 - 3498-
DESCRIPTION- KOZAK, Cell, (19860000), vol. 44, no. 2, pages 283 - 92-
DESCRIPTION- KOZAK, Nucleic Acids Res., (19870000), vol. 15, no. 20, pages 8125 - 48-
DESCRIPTION- KUNKEL et al., Methods in Enzymol, (19870000), vol. 154, pages 367 - 382-
DESCRIPTION- KUNKEL, Proc. Natl. Acad. Sci. USA., (19850000), vol. I & II, pages 488 - 492-
DESCRIPTION- KUTNER et al., Nature Protocols, (20090000), vol. 4, pages 495 - 505-
DESCRIPTION- LANDY, Current Opinion in Biotechnology, (19930000), vol. 3, pages 699 - 707-
DESCRIPTION- LEE, H. C. et al., Nature, (20000000), vol. 408, pages 483 - 460-
DESCRIPTION- LIN et al., Nature, (19990000), vol. 402, pages 128 - 129-
DESCRIPTION- LIU et al., Genes Dev., (19950000), vol. 9, page 1766-
DESCRIPTION- LOVELOCKBISHOP, Nature, (19590000), vol. 183, pages 1394 - 1395-
DESCRIPTION- LUPTON S. D. et al., Mol. and Cell. Biology, (19910000), vol. 1, no. 1, pages 3374 - 3378-
DESCRIPTION- MULLEN et al., Proc. Natl. Acad. Sci. USA., (19920000), vol. 89, page 33-
DESCRIPTION- N. R. LANDAU et al., J. Virol., (19920000), vol. 66, pages 5110 - 5113-
DESCRIPTION- OKA, K. et al., Curr. Opin. Lipidol., (20000000), vol. 11, pages 179 - 86-
DESCRIPTION- ORLANDI et al., PNAS, (19890000), vol. 86, pages 3833 - 3837-
DESCRIPTION- PATEL et al., Gene Therapy, (19990000), vol. 6, pages 412 - 419-
DESCRIPTION- PNAS, (19940000), vol. 113, pages 11099 - 11103-
DESCRIPTION- RIECHMANN L. et al., J. Immunol. Methods, (19990000), vol. 231, pages 25 - 38-
DESCRIPTION- RINFRET, Ann. N.Y. Acad. Sci., (19600000), vol. 85, page 576-
DESCRIPTION- RYAN et al., J. Gener. Virol., (19970000), vol. 78, pages 699 - 722-
DESCRIPTION- SAUER, B., Current Opinion in Biotechnology, (19940000), vol. 5, pages 521 - 527-
DESCRIPTION- SCHERAGA, Rev. Computational Chem, (19920000), pages 11173 - 142-
DESCRIPTION- SCYMCZAK et al., Nature Biotech., (20040000), vol. 5, pages 589 - 594-
DESCRIPTION- SHARP, Genes & Dev., (19990000), vol. 13, pages 139 - 141-
DESCRIPTION- SHIRATORY, Y et al., Liver, (19990000), vol. 19, pages 265 - 74-
DESCRIPTION- SIRIN et al., Gene, (20030000), vol. 323, page 67-
DESCRIPTION- SLOVITERRAVDIN, Nature, (19620000), vol. 196, page 48-
DESCRIPTION- SMITH-ARICA, J. R.BARTLETT, J. S., Curr. Cardiol. Rep., (20010000), vol. 3, pages 43 - 49-
DESCRIPTION- STRAYER, D. S., Expert Opin. Investig. Drugs, (19990000), vol. 8, pages 2159 - 2172-
DESCRIPTION- THULE, P. M.LIU, J. M., Gene Ther., (20000000), vol. 7, pages 1744 - 52-
DESCRIPTION- WIGLER et al., Cell, (19770000), vol. 11, page 223-
DESCRIPTION- WU, TTKABAT, E. A., J Exp Med., (19700000), vol. 132, no. 2, pages 211 - 50-
DESCRIPTION- YANG, N. S., Crit. Rev. Biotechnol., (19920000), vol. 12, pages 335 - 56-
DESCRIPTION- Y. SONEOKA et al., Nucl. Acids Res., (19950000), vol. 23, pages 628 - 633-
DESCRIPTION- ZENNOU et al., Cell, (20000000), vol. 101, pages 173 - 33-
DESCRIPTION- ZHAN et al., Hum. Genet., (20010000), vol. 109, page 471-
DESCRIPTION- ZUFFEREY et al., J. Virol., (19990000), vol. 73, page 2886-
OPPOSITION- Anonymous, "International Nonproprietary Ñames for Pharmaceutical Substances (INN)", WHO Drug Information, (20220101), vol. 36, no. 2, pages 305 - 306, 382-383, XP093141652-
OPPOSITION- CHALLITA PIA-MARIA ET AL, "Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased DNA methylation in embryonic carcinoma cells.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19950201), vol. 69, no. 2, ISSN 0022-538X, pages 748 - 755, XP002170227-
OPPOSITION- DULL T., ET AL., "A THIRD-GENERATION LENTIVIRUS VECTOR WITH A CONDITIONAL PACKAGING SYSTEM.", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19981101), vol. 72., no. 11., ISSN 0022-538X, pages 8463 - 8471., XP000872456-
OPPOSITION- Li Chunruii, "Poster Session 2 P-290: Updated long-term follow-up results of a phase lb/2 study (FUMANBA-1) in patients with relapsed/refractory multiple myeloma (RRMM) treated with Equecabtagene Autoleucel", IMS 20th Annual Meeting and Exposition, (20230928), pages 1 - 2, IMS 20th Annual Meeting and Exposition, URL: https://imsannual2023.eventscribe.net/, (20240315), XP093141651-
OPPOSITION- Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Richard G. Carroll, Gwendolyn K. Binder, David Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L. Riley, Stephan A. Grupp, Carl H. June, "Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo", Molecular Therapy, No longer published by Elsevier, (20090801), vol. 17, no. 8, doi:10.1038/mt.2009.83, ISSN 15250016, pages 1453 - 1464, XP055052474
OPPOSITION- Carl H. June, Bruce R. Blazar, James L. Riley, "Engineering lymphocyte subsets: tools, trials and tribulations", Nature Reviews Immunology, Nature Pub. Group, (20091001), vol. 9, no. 10, doi:10.1038/nri2635, ISSN 14741733, pages 704 - 716, XP055145648
OPPOSITION- Noopur raje, berdeja jesus et al., "Anti-BCMA CAR T-cell Therapy bb2121 in relapsed or refractory multiple myeloma", New England Journal of Medicine, The - NEJM, Massachusetts Medical Society, US, US , (20190502), vol. 380, no. 18, doi:10.1056/NEJMoa1817226, ISSN 1533-4406, pages 1726 - 1737, XP009516323
OPPOSITION- Munshi Nikhil C., Anderson Larry D., Shah Nina, Madduri Deepu, Berdeja Jesús, Lonial Sagar, Raje Noopur, Lin Yi, Siegel David, Oriol Albert, Moreau Philippe, Yakoub-Agha Ibrahim, Delforge Michel, Cavo Michele, Einsele Hermann, Goldschmidt Hartmut, Weisel Katja, Rambaldi Alessandro, Reece Donna, Petrocca Fabio, Massaro Monica, Connarn Jamie N., Kaiser Shari, Patel Payal, Huang Liping, Campbell Timothy B., Hege Kristen, San-Miguel Jesús, "Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20210225), vol. 384, no. 8, doi:10.1056/NEJMoa2024850, ISSN 0028-4793, pages 705 - 716, XP055951668
OPPOSITION- Rodriguez-Otero Paula, Ailawadhi Sikander, Arnulf Bertrand, Patel Krina, Cavo Michele, Nooka Ajay K., Manier Salomon, Callander Natalie, Costa Luciano J., Vij Ravi, Bahlis Nizar J., Moreau Philippe, Solomon Scott R., Delforge Michel, Berdeja Jesus, Truppel-Hartmann Anna, Yang Zhihong, Favre-Kontula Linda, Wu Fan, Piasecki Julia, Cook Mark, Giralt Sergio, "Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma", The New England journal of medicine, Massachusetts Medical Society, US, US , (20230316), vol. 388, no. 11, doi:10.1056/NEJMoa2213614, ISSN 0028-4793, pages 1002 - 1014, XP093141742
OPPOSITION- Satiro Nakamura De Oliveira, Christine Ryan, Francesca Giannoni, Cinnamon L. Hardee, Irena Tremcinska, Behrod Katebian, Jennifer Wherley, Arineh Sahaghian, Andy Tu, Tristan Grogan, David Elashoff, Laurence J.N. Cooper, Roger P. Hollis, Donald B. Kohn, "Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (20131001), vol. 24, no. 10, doi:10.1089/hum.2012.202, ISSN 1043-0342, pages 824 - 839, XP055244062
OPPOSITION- Friedman et al., "Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells", Human Gene Therapy, (2018), vol. 29, doi:10.1089/hum.2018.001, page 5, XP055626881
OPPOSITION- KOCHENDERFER JAMES N ET AL, "Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor", Journal of Immunotherapy, Lippincott Williams & Wilkins, US, US , (20120113), vol. 32, no. 7, doi:10.1097/CJI.0b013e3181ac6138, ISSN 1524-9557, pages 689 - 702, XP002667048
OPPOSITION- Larson Sarah M.; Tu Andy; Senadheera Shanta; Ho Michelle; Kohn Donald B.; deOliveira Satiro, "Anti-CD19 Chimeric Antigen Receptor Controlled By The Suicide Gene HSVsr39TK In Hematopoietic Stem Cells For Immunotherapy Of B-Lineage Malignancies", Blood, American Society of Hematology, US, US , (20131115), vol. 122, no. 21, doi:10.1182/blood.V122.21.1659.1659, ISSN 0006-4971, page 1659, XP086750234
SEARCH- LIN LIU ET AL, "Adoptive T-cell therapy of B-cell malignancies: Conventional and physiological chimeric antigen receptors", CANCER LETTERS, NEW YORK, NY, US, vol. 316, no. 1, doi:10.1016/J.CANLET.2011.10.027, ISSN 0304-3835, (20111019), pages 1 - 5, (20111029), XP028434062 [A] 1-15 * the whole document *
SEARCH- W K CHAN ET AL, "Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity", LEUKEMIA., US, (20150201), vol. 29, no. 2, doi:10.1038/leu.2014.174, ISSN 0887-6924, pages 387 - 395, XP055403336 [AP] 1-15 * the whole document *
SEARCH- BLYTHE D SATHER ET AL, "Development of B-lineage Predominant Lentiviral Vectors for Use in Genetic Therapies for B Cell Disorders", MOLECULAR THERAPY, US, (20110301), vol. 19, no. 3, doi:10.1038/mt.2010.259, ISSN 1525-0016, pages 515 - 525, XP055416833 [A] 1-15 * the whole document *
SEARCH- SATIRO NAKAMURA DE OLIVEIRA ET AL, "Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy", HUMAN GENE THERAPY, US, (20131001), vol. 24, no. 10, doi:10.1089/hum.2012.202, ISSN 1043-0342, pages 824 - 839, XP055244062 [A] 1-15 * figure 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents